Evidence for a low-penetrant extended phenotype of rhabdoid tumor predisposition syndrome type 1 from a kindred with gain of SMARCB1 exon 6

Pediatr Blood Cancer. 2021 Oct;68(10):e29185. doi: 10.1002/pbc.29185. Epub 2021 Jun 8.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor
  • Brain Neoplasms* / genetics
  • Exons
  • Humans
  • Kidney Neoplasms* / genetics
  • Phenotype
  • Rhabdoid Tumor* / genetics
  • SMARCB1 Protein* / genetics

Substances

  • Biomarkers, Tumor
  • SMARCB1 Protein
  • SMARCB1 protein, human

Supplementary concepts

  • Rhabdoid Tumor Predisposition Syndrome 1